We are live on ! Find out more
KALA icon

KALA BIO
KALA

63 hedge funds and large institutions have $2.27M invested in KALA BIO in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 22 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

875% more call options, than puts

Call options by funds: $39K | Put options by funds: $4K

0.01% less ownership

Funds ownership: 0.01% → 0% (-0.01%)

23% less funds holding

Funds holding: 82 → 63 (-19)

55% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 22

58% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 26

93% less capital invested

Capital invested by funds: $33.7M → $2.27M (-$31.4M)

Holders
63
Holders Change
-19
Holders Change %
-23.17%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
22
Closed
26
Calls
$39K
Puts
$4K
Net Calls
+$35K
Net Calls Change
+$128K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$328K
2
E
Ergoteles
New York
+$138K
3
Goldman Sachs
Goldman Sachs
New York
+$97.3K
4
Citadel Advisors
Citadel Advisors
Florida
+$59.6K
5
Renaissance Technologies
Renaissance Technologies
New York
+$58.1K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$15M
2
BlackRock
BlackRock
New York
-$1.47M
3
GL
Graypoint LLC
New York
-$672K
4
State Street
State Street
Massachusetts
-$604K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$319K
Name Holding Trade Value Shares
Change 		Change in
Stake
MA
51
MCF Advisors
Kentucky
$3K – – –
Wells Fargo
52
Wells Fargo
California
$2K -$4.71K -3 -60%
EW
53
Evoke Wealth
California
$2K – – –
Skandinaviska Enskilda Banken (SEB)
54
Skandinaviska Enskilda Banken (SEB)
Sweden
$2K – – –
SPIA
55
Steward Partners Investment Advisory
New York
$2K – – –
Bank of America
56
Bank of America
North Carolina
$1K -$298K -190 -99%
Fidelity Investments
57
Fidelity Investments
Massachusetts
$1K -$4.71K -3 -60%
Federated Hermes
58
Federated Hermes
Pennsylvania
$1K – – –
Legal & General Group
59
Legal & General Group
United Kingdom
$1K – – –
Northwestern Mutual Wealth Management
60
Northwestern Mutual Wealth Management
Wisconsin
$1K +$1.57K +1 New
RCM
61
RA Capital Management
Massachusetts
– -$15M -4,354 Closed
GL
62
Graypoint LLC
New York
– -$672K -195 Closed
BCM
63
Bridgeway Capital Management
Texas
– -$242K -70 Closed
N
64
Nuveen
North Carolina
– -$250K -65 Closed
Charles Schwab
65
Charles Schwab
California
– -$156K -45 Closed
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
– -$115K -33 Closed
MCM
67
MAI Capital Management
Ohio
– -$100K -29 Closed
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
– -$94K -27 Closed
AllianceBernstein
69
AllianceBernstein
Tennessee
– -$77K -22 Closed
JP Morgan Chase
70
JP Morgan Chase
New York
– -$32.9K -21 -95%
AG
71
Algert Global
California
– -$54K -16 Closed
D.E. Shaw & Co
72
D.E. Shaw & Co
New York
– -$41K -12 Closed
Deutsche Bank
73
Deutsche Bank
Germany
– -$39K -11 Closed
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
– -$17.3K -11 Closed
AIG
75
American International Group
New York
– -$34K -10 Closed
1 2
3
4

KALA Hedge Fund Activity: Q2 2022 in Review

63 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2022, worth a combined $2.27M — down 93% from $33.7M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of KALA and 11 opened new positions — a net loss of 15 holders — while 22 trimmed existing stakes and 10 added.

The largest buyer was Millennium Management, adding an estimated $328K. The largest seller was RA Capital Management, exiting entirely with an estimated $15M sold.

  • 63 institutional investors held KALA BIO (KALA) as of Q2 2022, down from 82 in Q1 2022.
  • Funds reported $2.27M of KALA BIO stock for Q2 2022, down 93% quarter-over-quarter.
  • 11 funds opened new KALA BIO positions in Q2 2022 and 26 closed out, a net change of -15 holders.
  • The largest KALA BIO buyer in Q2 2022 was Millennium Management, an estimated $328K added.
  • The largest KALA BIO seller in Q2 2022 was RA Capital Management, an estimated $15M sold.

Based on aggregated 13F filings for Q2 2022.